Oracle got upgraded to Buy on June 11 — by Zacks, whose rating system ignores narratives and tracks one thing: the direction of earnings estimates. The stock was down 2.21% to $201.26 on the day, which is exactly why the upgrade is worth a look.
| Metric | Value |
|---|---|
| Rating | Zacks Rank #2 (Buy) |
| Price | $201.26 (-2.21% on the day) |
| FY2026 EPS estimate | $7.46 |
| Estimate revision (3 mo.) | +1.6% |
| Revisions rank | Top 20% of covered stocks |
Why it moved
Estimate-revision upgrades are the least glamorous signal in markets and one of the most reliable: stocks with rising estimates systematically outperform, because analysts revise in small steps and the market underreacts to each one. Oracle's consensus has climbed 1.6% in three months, putting it in the top quintile of all covered names. That happens when the underlying business — in Oracle's case, cloud infrastructure demand fed by AI training contracts — keeps coming in slightly better than modeled, quarter after quarter.
What it means for you
A flat year-over-year EPS print ($7.46) is not the story; the trajectory of revisions is. Oracle has transformed from a legacy database vendor into one of the serious AI-era cloud landlords, and the market still argues about how durable that backlog is. Rising estimates on a down-2% day is the kind of divergence that resolves upward more often than not.
Bottom line: I treat dips in estimate-revision leaders as accumulation windows, not warnings. ORCL near $200 with estimates trending up is a setup I would rather buy than the same stock 10% higher on a euphoric headline.